Page last updated: 2024-08-21

diphenylamine and Squamous Cell Carcinoma of Head and Neck

diphenylamine has been researched along with Squamous Cell Carcinoma of Head and Neck in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Carter-Cooper, BA; Cullen, KJ; Dan, H; Lapidus, RG; Liao, J; Yang, Z	1
Carlson, SG; Chen, Z; Cheng, H; Coupar, JF; Eytan, DF; Mohan, S; Pierce, ML; Shah, S; Van Waes, C; Vander Broek, R; Zhang, J	1

Other Studies

2 other study(ies) available for diphenylamine and Squamous Cell Carcinoma of Head and Neck

Article	Year
Regulation of cisplatin-resistant head and neck squamous cell carcinoma by the SRC/ETS-1 signaling pathway. BMC cancer, 2019, May-22, Volume: 19, Issue:1 Topics: Benzamides; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cisplatin; Dasatinib; Diphenylamine; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Humans; MAP Kinase Signaling System; Phosphorylation; Proto-Oncogene Protein c-ets-1; Signal Transduction; Squamous Cell Carcinoma of Head and Neck; src-Family Kinases; Up-Regulation	2019
MEK Inhibitor PD-0325901 Overcomes Resistance to PI3K/mTOR Inhibitor PF-5212384 and Potentiates Antitumor Effects in Human Head and Neck Squamous Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research, 2015, Sep-01, Volume: 21, Issue:17 Topics: Animals; Antineoplastic Agents; Benzamides; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; Cytokines; Diphenylamine; Disease Models, Animal; Drug Resistance, Neoplasm; Drug Synergism; Gene Expression; Genes, Reporter; Head and Neck Neoplasms; Humans; Inflammation Mediators; Mitogen-Activated Protein Kinase Kinases; Morpholines; NF-kappa B; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Protein Kinase Inhibitors; Signal Transduction; Squamous Cell Carcinoma of Head and Neck; TOR Serine-Threonine Kinases; Transcription Factor AP-1; Transcriptional Activation; Triazines; Xenograft Model Antitumor Assays	2015

Article

Year

Regulation of cisplatin-resistant head and neck squamous cell carcinoma by the SRC/ETS-1 signaling pathway.

BMC cancer, 2019, May-22, Volume: 19, Issue:1

Topics: Benzamides; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cisplatin; Dasatinib; Diphenylamine; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Humans; MAP Kinase Signaling System; Phosphorylation; Proto-Oncogene Protein c-ets-1; Signal Transduction; Squamous Cell Carcinoma of Head and Neck; src-Family Kinases; Up-Regulation

2019

MEK Inhibitor PD-0325901 Overcomes Resistance to PI3K/mTOR Inhibitor PF-5212384 and Potentiates Antitumor Effects in Human Head and Neck Squamous Cell Carcinoma.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2015, Sep-01, Volume: 21, Issue:17

Topics: Animals; Antineoplastic Agents; Benzamides; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; Cytokines; Diphenylamine; Disease Models, Animal; Drug Resistance, Neoplasm; Drug Synergism; Gene Expression; Genes, Reporter; Head and Neck Neoplasms; Humans; Inflammation Mediators; Mitogen-Activated Protein Kinase Kinases; Morpholines; NF-kappa B; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Protein Kinase Inhibitors; Signal Transduction; Squamous Cell Carcinoma of Head and Neck; TOR Serine-Threonine Kinases; Transcription Factor AP-1; Transcriptional Activation; Triazines; Xenograft Model Antitumor Assays

2015